Through the consistent efforts of National Community Pharmacists Association (NCPA), the Small Business Administration sent a comment letter to CMS supporting independent pharmacy’s stance on the Medicare Part D proposed rule for Contract Year 2023. The SBA submitted these comments on behalf of small business pharmacies and relied on data provided by NCPA. In the letter, the agency highlights several issues NCPA raised in our own letter regarding the potential policy changes, including clarification on claw-backs, a more complete definition to capture PBM fees, a standardized set of performance measures, and potential ways to address cash-flow issues should the rule be implemented. NCPA welcomes SBA recognizing the issues with the rule as proposed and weighing in with another executive agency on behalf of our membership. NCPA will continue to work with CMS through the regulatory process.
top of page
bottom of page